Fadlo R. Khuri, MD, FACP
Oncologist, physician, and Professor, Fadlo R. Khuri, MD, FACP, has been recognized by the International Association for the Study of Lung Cancer (IASLC) with a Distinguished Award at the IASLC 19th World Conference on Lung Cancer (WCLC) in Toronto. Dr. Khuri received the Joseph W. Cullen Prevention/Early Detection Award, honoring his lifetime scientific achievements in research on the prevention of thoracic malignancies.
Dr. Khuri is the current President of and Professor of Medicine at the American University of Beirut in Lebanon. He also is Professor on long-term leave in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Khuri has directed research on oncolytic viral therapy, molecular-targeted therapeutic approaches, and chemoprevention efforts for lung as well as head and neck cancers. In addition, his team has focused on the mechanisms of action of signal transduction inhibitors in lung and aerodigestive cancers.
Fred R. Hirsch, MD, PhD
“Dr. Fadlo Khuri has for many years been a pioneer in pursuing the importance of early detection and particularly the treatment of premalignant conditions leading to lung cancer. He has also been a strong advocate for the concept of diagnosis of premalignancies and treatment approaches before the condition becomes an invasive cancer,” said Fred R. Hirsch, MD, PhD, Chief Executive Officer of the IASLC. “Dr. Khuri’s groundbreaking studies and approaches are encouraging and inspiring in our fight to reduce lung cancer burden and mortality in the future through early intervention.” ■
